Jazz Pharmaceuticals plc (J7Z) — Cash Flow-to-Debt Ratio
Jazz Pharmaceuticals plc (J7Z) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of €408.20 Million could theoretically repay 0% of its total liabilities (€7.33 Billion) in one year. Explore Jazz Pharmaceuticals plc strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jazz Pharmaceuticals plc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Jazz Pharmaceuticals plc across 13 annual periods. Also explore Jazz Pharmaceuticals plc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jazz Pharmaceuticals plc (2013–2025)
Year-by-year debt coverage analysis for Jazz Pharmaceuticals plc. For market capitalisation and broader financial context, see Jazz Pharmaceuticals plc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | €1.36 Billion | €7.34 Billion | ▲ +4.8% |
| 2024 | 0.18x | €1.40 Billion | €7.92 Billion | ▲ +23.6% |
| 2023 | 0.14x | €1.09 Billion | €7.66 Billion | ▼ -13.1% |
| 2022 | 0.16x | €1.27 Billion | €7.75 Billion | ▲ +75.7% |
| 2021 | 0.09x | €778.51 Million | €8.33 Billion | ▼ -70.1% |
| 2020 | 0.31x | €899.65 Million | €2.88 Billion | ▼ -2.2% |
| 2019 | 0.32x | €776.40 Million | €2.43 Billion | ▼ -2.1% |
| 2018 | 0.33x | €798.90 Million | €2.45 Billion | ▲ +13.6% |
| 2017 | 0.29x | €693.09 Million | €2.41 Billion | ▲ +41.9% |
| 2016 | 0.20x | €592.39 Million | €2.92 Billion | ▼ -33.9% |
| 2015 | 0.31x | €531.94 Million | €1.73 Billion | ▲ +48.1% |
| 2014 | 0.21x | €407.61 Million | €1.97 Billion | ▼ -32.3% |
| 2013 | 0.31x | €288.43 Million | €942.69 Million | — |